PTC Therapeutics (PTCT)
Develops rare-disease medicines spanning PKU, DMD, gene therapy, and RNA-splicing programs.
$65.96
After hours+0.01 (+0.02%)
At close$65.95(+1.06%)
Something off on this page? Send us feedback.
Next report
Nov 3, 26
in 42 days
EPS estimate
$0.29
Revenue estimate
$303.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported−$0.85$10.04−$0.83$0.20−$1.67−$0.03$0.92Pending
Estimate−$1.12−$1.08−$1.07−$1.19−$0.21−$0.45$0.24$0.29
Surprise+24.1%+1,029.6%+22.4%+116.8%−695.2%+93.3%+289.3%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$213.2M$1.18B$178.9M$211.0M$164.7M$272.6M$360.5MPending
Estimate$232.4M$372.6M$191.5M$281.5M$279.5M$217.4M$298.6M$303.9M
Surprise−8.3%+215.6%−6.6%−25.0%−41.1%+25.4%+20.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.51 | — | — |
| Sep 2027 | $0.42 | — | — |
| Jun 2027 | $0.46 | — | — |
| Mar 2027 | −$0.16 | — | — |
| Dec 2026 | $0.23 | — | — |
| Nov 2026 | $0.29 | — | — |
| Jul 2026 | $0.24 | $0.92 | +289.3% |
| May 2026 | −$0.45 | −$0.03 | +93.3% |
| Feb 2026 | −$0.21 | −$1.67 | −695.2% |
| Nov 2025 | −$1.19 | $0.20 | +116.8% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| Apr 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Aug 2023 | |||
| Apr 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| Apr 2020 | |||
| Mar 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Jul 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.51 | — | — | $330.1M | — | — | — |
| Sep 2027 | $0.42 | — | — | $319.6M | — | — | — |
| Jun 2027 | $0.46 | — | — | $324.4M | — | — | — |
| Mar 2027 | −$0.16 | — | — | $281.0M | — | — | — |
| Dec 2026 | $0.23 | — | — | $320.5M | — | — | — |
| Nov 3, 2026 | $0.29 | — | — | $303.9M | — | — | — |
| Jul 30, 2026 | $0.24 | $0.92 | +289.3% | $298.6M | $360.5M | +20.7% | −9.9% |
| May 7, 2026 | −$0.45 | −$0.03 | +93.3% | $217.4M | $272.6M | +25.4% | +14.3% |
| Feb 19, 2026 | −$0.21 | −$1.67 | −695.2% | $279.5M | $164.7M | −41.1% | +1.1% |
| Nov 4, 2025 | −$1.19 | $0.20 | +116.8% | $281.5M | $211.0M | −25.0% | +6.0% |
| Aug 7, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| Apr 25, 2024 | |||||||
| Feb 29, 2024 | |||||||
| Oct 26, 2023 | |||||||
| Aug 3, 2023 | |||||||
| Apr 27, 2023 | |||||||
| Feb 21, 2023 | |||||||
| Oct 27, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 3, 2022 | |||||||
| Feb 22, 2022 | |||||||
| Oct 28, 2021 | |||||||
| Jul 29, 2021 | |||||||
| May 4, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Aug 5, 2020 | |||||||
| Apr 30, 2020 | |||||||
| Mar 2, 2020 | |||||||
| Oct 29, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 2, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Nov 5, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 9, 2018 | |||||||
| Mar 6, 2018 | |||||||
| Nov 2, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 8, 2017 | |||||||
| Mar 16, 2017 | |||||||
| Nov 2, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 5, 2016 | |||||||
| Feb 29, 2016 | |||||||
| Nov 9, 2015 | |||||||
| Jul 30, 2015 |